Power Wheelchair Group 2 denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's Commercial policy states that mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POVs), canes, and walkers are a covered health care service when medically necessary. The policy applies the Medicare DME MAC LCD for Power Mobility Devices (L33789) criteria, which require that the beneficiary has a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home, where the mobility limitation prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completion within a reasonable time frame. The beneficiary's mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. For a Group 2 Single Power Option PWC (K0835–K0840), all basic coverage criteria (a)–(e) must be met, plus the beneficiary requires a drive control interface other than a hand or chin-operated standard proportional joystick (e.g., head control, sip and puff, switch control), OR meets coverage criteria for a power tilt or power recline seating system being used on the wheelchair, AND has had a specialty evaluation performed by a licensed/certified medical professional (PT, OT, or practitioner) with specific training and experience in rehabilitation wheelchair evaluations documenting medical necessity. The wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) who specializes in wheelchairs and has direct, in-person involvement in the wheelchair selection. Section 6407 of the ACA requires a face-to-face encounter, documented by a physician (or NP, PA, or CNS), occurring within the 6 months before the order is written for the DME. Weight-class criteria apply: a Heavy Duty PWC is covered for beneficiaries weighing 285–450 pounds, Very Heavy Duty for 428–600 pounds, and Extra Heavy Duty for 570 pounds or more. Payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document in-home MRADL impairment in detail** — Provide specific examples of how the member cannot independently/safely complete toileting, feeding, dressing, grooming, or bathing in the home, mapping directly to the LCD MRADL definition: a mobility limitation that prevents accomplishment of an MRADL, places the beneficiary at heightened risk of morbidity/mortality, or prevents completion within a reasonable time frame. - **Demonstrate failure of lesser alternatives** — Include PT/OT trial documentation showing that the beneficiary lacks sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day due to weakness, fatigue, pain, ROM limits, or absent extremities, satisfying LCD basic criterion C. - **Submit a compliant specialty evaluation and ATP attestation** — Provide the LCMP/PT/OT evaluation with the no-financial-relationship attestation per the requirement of a signed and dated attestation by the supplier or LCMP that the LCMP has no financial relationship with the supplier , plus documentation that the wheelchair is provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) who specializes in wheelchairs and has direct, in-person involvement in the wheelchair selection. - **Justify the Group 2 power option upgrade** — For K0835–K0840, document either a non-standard drive control need (head control, sip-and-puff, switch) OR concurrent need for a power tilt/recline system per the LCD requirement that the beneficiary requires a drive control interface other than a hand or chin-operated standard proportional joystick, or meets coverage criteria for a power tilt or power recline seating system being used on the wheelchair. - **Provide a timely 7-element order and face-to-face note** — Submit the in-window F2F note and order; per the LCD policy article, the 7-element order must be received by the supplier within 45 days after completion of the face-to-face examination , and per CMS, the encounter must occur within the 6 months before the order is written. - **Verify accurate weight-class coding** — Confirm the member's weight aligns with the prescribed class boundaries set by the LCD: Heavy Duty 285–450 lb, Very Heavy Duty 428–600 lb, and Extra Heavy Duty 570 lb or more , and amend the HCPCS code if a misclassification triggered the denial. - **Cite clinical/professional standards** — Reference RESNA's position papers on the application of power wheelchairs and seat-elevation/tilt systems, and AOTA/APTA wheelchair assessment guidelines, to support the medical necessity narrative that mirrors LCD L33789 — the framework UnitedHealthcare explicitly adopts via its Mobility Devices policy and the DME MAC LCD for Power Mobility Devices (L33789).

## UnitedHealthcare Medicare Advantage — Power Wheelchair Group 2 (K0835–K0843): Prior-Auth-Required Denials

A "prior authorization required" denial on a Group 2 power wheelchair from UnitedHealthcare Medicare Advantage is rarely a true clinical denial — it is a procedural gate under UHC's DME Coverage Summary, which delegates substantive coverage to DME MAC LCD L33789 (Power Mobility Devices) and LCD L33792 (Wheelchair Options/Accessories). Because UHC MA is an MA-PD plan, the prior-authorization mechanic is governed by 42 CFR §422.566 (organization determinations) and 42 CFR §422.568 (14-day standard / 72-hour expedited turnaround). Missing those deadlines triggers an automatic forward to the IRE (MAXIMUS) under 42 CFR §422.590 — a lever most suppliers underuse.

The most common procedural failure points are: (1) absence of a Standard Written Order (SWO) signed and dated before delivery listing the base HCPCS plus every separately billed accessory (a 2023 CMS requirement now enforced strictly by Optum/naviHealth reviewers); (2) a Face-to-Face mobility examination that does not document the MRADL limitation (toileting, feeding, dressing, grooming, bathing) in customary locations in the home — generic "difficulty walking" language fails L33789 criterion (a); (3) no PT/OT specialty evaluation for Single Power Option (K0835–K0840) or Multiple Power Option (K0841–K0843) chairs, which LCD L33789 mandates whenever the chair has non-standard drive controls, power tilt/recline, or expandable electronics; and (4) for K0841–K0843, failure to document the qualifying neurologic condition, myopathy, congenital skeletal deformity, or ventilator dependence.

UHC's PA portal routes Group 2 PMD requests through Optum / naviHealth post-acute review for many MA contracts — a different reviewer pool than commercial DME. naviHealth applies LCD criteria narrowly and often issues "insufficient documentation" denials that read as medical-necessity denials but are remediable on reconsideration with a properly assembled packet. Under 29 CFR §2560.503-1(g) (and the parallel MA disclosure standards at 42 CFR §422.568(e)), UHC must identify the specific missing element — a generic "PA required" letter is appealable on its face.

Note that 42 CFR §422.101(b)(2) binds MA plans to CMS National and Local Coverage Determinations as a coverage floor. UHC cannot apply criteria more restrictive than LCD L33789 — a frequent overreach in naviHealth denials demanding repeat ATP evaluations or trial-of-lesser-equipment beyond what the LCD requires.

Tactical tip: File the reconsideration as expedited under 42 CFR §422.570 when the member's mobility status creates safety risk (fall history, pressure injury, caregiver inability to transfer) — this compresses UHC's clock to 72 hours and shifts the IRE escalation timeline forward by 11 days. Attach the SWO, F2F note with explicit MRADL mapping, PT/OT specialty eval, and a cover letter citing L33789 criteria by letter (a)–(e) with pinpoint chart references. If naviHealth denies again, demand the MAC LCD as the binding standard under 42 CFR §422.101(b)(2) in the Level 2 IRE submission.